InvestorsHub Logo

Investor2014

05/11/21 1:50 PM

#309698 RE: bb8675309 #309666

That is because Anavex Life Sciences is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.


Yeah right Zacks really on top of this stock.